StreetInsider.com News Articles

Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report

Thu, 23 Jul 2026 09:05:00 -0400

TUSTIN, Calif.--(BUSINESS WIRE)--

Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) (Nasdaq: SBRA) today released its sixth annual Sustainability Report for fiscal year 2025.

The report highlights how Sabra is scaling successful pilot technologies into portfolio-wide initiatives, expanding solutions that improve care delivery and continuing to invest in resilient, efficient operations. Together with the Company's broader sustainability efforts, these initiatives reflect Sabra’s continued integration of sustainability into its business strategy, helping tenants and operators improve quality of life for residents, creating healthier environments for staff and strengthening the long-term resilience of its portfolio. Grounded in

Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report

Thu, 23 Jul 2026 09:05:00 -0400

TUSTIN, Calif.--(BUSINESS WIRE)--

Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) (Nasdaq: SBRA) today released its sixth annual Sustainability Report for fiscal year 2025.

Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report

Thu, 23 Jul 2026 09:05:00 -0400

TUSTIN, Calif.--(BUSINESS WIRE)--

Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) (Nasdaq: SBRA) today released its sixth annual Sustainability Report for fiscal year 2025.

Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report

Thu, 23 Jul 2026 09:05:00 -0400

TUSTIN, Calif.--(BUSINESS WIRE)--

Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) (Nasdaq: SBRA) today released its sixth annual Sustainability Report for fiscal year 2025.

Sabra Healthcare REIT Inc. (SBRA) PT Raised to $25 at Deutsche Bank

Wed, 22 Jul 2026 07:26:12 -0400

Deutsche Bank analyst Omotayo Okusanya raised the price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $25.00 (from $22.00) while maintaining a Buy rating.

Sabra Healthcare REIT Inc. (SBRA) PT Raised to $24 at Truist Securities

Wed, 22 Jul 2026 07:08:30 -0400

Truist Securities analyst Michael Lewis raised the price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $24.00 (from $22.00) while maintaining a Buy rating.

Sabra Healthcare REIT Inc. (SBRA) PT Raised to $23 at Baird

Wed, 22 Jul 2026 06:22:22 -0400

Baird analyst David Rodgers raised the price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $23.00 (from $22.00) while maintaining a Neutral rating.

Sabra Healthcare REIT (SBRA) PT Raised to $25 at Citizens on Guidance Raise, Business Update

Wed, 22 Jul 2026 04:11:02 -0400

Citizens analyst Aaron Hecht raised the price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $25.00 (from $23.00) while maintaining a Market Outperform rating.

The analyst commented, "We reiterate our Market Outperform rating and raise our price target to $25 (15x 2027E FAD) from $23 (15x 2026E FAD) after SBRA issued a business update and raised full-year 2026 guidance. On Tuesday, July 21, SBRA updated investors on multiple areas of operations including released space resulting in $12mm net additional annualized rent, another few strategic transactions that will increase annualized cash NOI by $9mm, and received $200mm related to a mortgage

Sabra Healthcare REIT (SBRA) PT Raised to $25 at Citizens on Guidance Raise, Business Update

Wed, 22 Jul 2026 04:11:02 -0400

Citizens analyst Aaron Hecht raised the price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $25.00 (from $23.00) while maintaining a Market Outperform rating.

Sabra Health Care REIT (SBRA) 3300 contracts of August 22.5 calls trade, share price up 9.3%

Tue, 21 Jul 2026 15:04:00 -0400

Sabra Health Care REIT (NASDAQ: SBRA) 30-day call option implied volatility is 24; compared to its 52-week range of 14 to 35 with a focus on 3300 contracts of August 22.5 calls as share price up 9.3%.

Sabra Health Care REIT (SBRA) 3300 contracts of August 22.5 calls trade, share price up 9.3%

Tue, 21 Jul 2026 15:04:00 -0400

Sabra Health Care raises 2026 guidance amid tenant, mortgage moves

Tue, 21 Jul 2026 09:05:59 -0400

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) raised its full-year 2026 earnings guidance after announcing plans to re-tenant 26 properties previously leased to Avamere and settling a $300 million mortgage at a reduced amount, according to a company statement.

Under letters of intent, 22 of the Avamere properties would be transferred to subsidiaries of Cascadia Healthcare, while the remaining four would go to an existing Sabra tenant. The combined annualized cash rent from the portfolio is expected to reach $53 million upon closing, compared with $41 million received from Avamere in the trailing twelve months ending March 31, 2026. The transition

Sabra Health Care raises 2026 guidance amid tenant, mortgage moves

Tue, 21 Jul 2026 09:05:59 -0400

Sabra Issues Business Update and Increases Full-Year 2026 Guidance